APVO
Aptevo Therapeutics
$4.21
−$0.18 (−4.1%)Jul 27, 2026
Key metrics
The numbers that frame APVO today
- Market cap
- $5.25M
- P/E (TTM)
- -0.2
- EV / FCF
- 0.2
- ROIC
- -551.7%
- Div yield
- 0%
- Debt / equity
- 0.4
- 52wk Low
- $3.72
- 52wk High
- $59.04
Growth
Revenue and earnings trend for APVO
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about APVO
Is Aptevo Therapeutics a good buy?
No. Aptevo Therapeutics has poor quality and poor momentum. Both signals point to a weaker setup. Growth looks poor. That could put pressure on the long-term business case.
What is the market capitalization of APVO?
Aptevo Therapeutics's market capitalization is $5.25M.
What is the P/E ratio for APVO stock?
Aptevo Therapeutics's current P/E ratio is -0.2.
What is the 52-week high for APVO stock?
The 52-week high for Aptevo Therapeutics is $59.04. The current close of $4.21 is 92.9% below that high.
What is the 52-week low for APVO stock?
The 52-week low for Aptevo Therapeutics is $3.72. The current close of $4.21 is 13.2% above that low.
Does APVO stock pay dividends?
Aptevo Therapeutics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for APVO?
Aptevo Therapeutics's Debt / Equity ratio is 0.38.